🚨 Revolutionizing Diabetes Care — No Fridge Required! 💉🔥
A major leap in insulin innovation is here, straight from
@IITKanpur 🇮🇳
Prof. Sandeep Verma & Prof. S. Ganesh have developed next-gen thermostable human insulin analogs that resist heat, avoid fibrillation, and retain full biological activity — even in challenging storage conditions. 🌡️🧬
🌍Why it matters:
For millions of people with diabetes, daily insulin injections are non-negotiable. But insulin’s tendency to degrade under heat or during transport puts lives at risk — especially in resource-limited or tropical regions.
🔬What’s the breakthrough?
The new analogs:
✅ Show prolonged thermal stability
✅ Resist fibrillation far longer than native insulin
✅ Preserve bioactivity in vitro, ex vivo, and in vivo
✅ Achieve added stability via π–π stacking & hydrogen bonding
🚀Enter Stablin Biosciences — a biotech startup born from this innovation!
🔬Now advancing toward TRL 6–7, the team is actively seeking funding for pre-clinical trials in higher animal models to push this life-saving solution toward reality.
📖Read the full research published in Nature Communications Chemistry:
🔗
nature.com/articles/s42004-0…
💡A homegrown solution with global health impact — ensuring safe, stable insulin access anytime, anywhere. Proud moment for India’s med-tech ecosystem! 🇮🇳💊
#IITKanpur #StablinBiosciences #ThermostableInsulin #InsulinInnovation #DiabetesCare #GlobalHealth #BiotechIndia #MedTech #TRL7 #MadeInIndia #HealthcareEquity #ColdChainFree #FutureOfMedicine #BiotechStartups